Tryton Medical Announces New CEO and President

Written By Shannon Beyer

DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the company has appointed Carl J. St. Bernard as president and chief executive officer…

Shannon Beyer
Previous

Respicardia Announces First U.S. Commercial Case with the remedē® System; Industry Veteran Peter Sommerness Joins as CEO to Lead U.S. Launch
Next

Vascular Dynamics Appoints Ed Roschak CEO